BE782651A - Produit a base d'insuline - Google Patents

Produit a base d'insuline

Info

Publication number
BE782651A
BE782651A BE782651A BE782651A BE782651A BE 782651 A BE782651 A BE 782651A BE 782651 A BE782651 A BE 782651A BE 782651 A BE782651 A BE 782651A BE 782651 A BE782651 A BE 782651A
Authority
BE
Belgium
Prior art keywords
insulin
based product
product
Prior art date
Application number
BE782651A
Other languages
English (en)
Inventor
R L Jackson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BE782651A publication Critical patent/BE782651A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
BE782651A 1971-04-30 1972-04-26 Produit a base d'insuline BE782651A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13912071A 1971-04-30 1971-04-30

Publications (1)

Publication Number Publication Date
BE782651A true BE782651A (fr) 1972-10-26

Family

ID=22485216

Family Applications (1)

Application Number Title Priority Date Filing Date
BE782651A BE782651A (fr) 1971-04-30 1972-04-26 Produit a base d'insuline

Country Status (23)

Country Link
US (1) US3758683A (fr)
JP (1) JPS5735185B1 (fr)
BE (1) BE782651A (fr)
CA (1) CA976085A (fr)
CH (1) CH566784A5 (fr)
CS (1) CS209458B2 (fr)
DD (1) DD100708A5 (fr)
DE (1) DE2219635C3 (fr)
DK (1) DK131760C (fr)
ES (1) ES402176A1 (fr)
FI (1) FI49773C (fr)
FR (1) FR2134658B1 (fr)
GB (1) GB1385086A (fr)
HU (1) HU166989B (fr)
IL (1) IL39181A (fr)
NL (1) NL178258C (fr)
NO (1) NO137178C (fr)
PL (1) PL86966B1 (fr)
RO (1) RO64387A (fr)
SE (1) SE378066B (fr)
SU (1) SU508162A3 (fr)
YU (1) YU36155B (fr)
ZA (1) ZA722243B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK140801B (da) * 1975-01-15 1979-11-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.
NL193099C (nl) * 1981-10-30 1998-11-03 Novo Industri As Gestabiliseerde insuline-oplossing.
WO1988002633A1 (fr) * 1986-10-20 1988-04-21 Novo Industri A/S Preparatiosn d'insuline avec du zinc et des protamines
IE62879B1 (en) * 1987-02-25 1995-03-08 Novo Nordisk As Novel insulin derivatives
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
US6624141B1 (en) * 1999-03-17 2003-09-23 The Regents Of The University Of Michigan Protamine fragment compositions and methods of use
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
TR201809460T4 (tr) 2009-11-13 2018-07-23 Sanofi Aventis Deutschland Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.
JP5973918B2 (ja) 2009-11-13 2016-08-23 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｇｌｐ−１アゴニスト及びメチオニンを含む薬学的組成物
JP6199186B2 (ja) 2010-08-30 2017-09-20 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ２型糖尿病の治療用の医薬の製造のためのａｖｅ００１０の使用
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087693A1 (es) 2011-08-29 2014-04-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CA2970200A1 (fr) 2014-12-12 2016-06-16 Sanofi-Aventis Deutschland Gmbh Formulation contenant un rapport fixe d'insuline glargine/lixisenatide
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
CN111050750A (zh) 2017-08-24 2020-04-21 诺沃挪第克公司 Glp-1组合物及其用途
EP4106727A1 (fr) 2020-02-18 2022-12-28 Novo Nordisk A/S Formulations pharmaceutiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5038E (fr) * 1904-03-09 1905-12-02 Georges Frederic Brade Perfectionnements dans la fabrication des organes du métronome
GB889769A (en) * 1957-07-18 1962-02-21 Nordisk Insulinlab Slowly acting insulin preparation in crystalline form

Also Published As

Publication number Publication date
US3758683A (en) 1973-09-11
YU36155B (en) 1982-02-25
YU114272A (en) 1981-06-30
CA976085A (en) 1975-10-14
ES402176A1 (es) 1975-03-01
CH566784A5 (fr) 1975-09-30
DE2219635C3 (de) 1981-10-15
DK131760C (da) 1976-02-02
IL39181A0 (en) 1972-06-28
NL178258B (nl) 1985-09-16
DE2219635B2 (de) 1980-11-27
DE2219635A1 (de) 1972-11-09
FI49773B (fr) 1975-06-30
FR2134658B1 (fr) 1975-10-17
NL178258C (nl) 1986-02-17
NO137178B (no) 1977-10-10
DD100708A5 (fr) 1973-10-05
GB1385086A (en) 1975-02-26
IL39181A (en) 1974-09-10
JPS5735185B1 (fr) 1982-07-27
PL86966B1 (fr) 1976-06-30
SU508162A3 (ru) 1976-03-25
FR2134658A1 (fr) 1972-12-08
DK131760B (da) 1975-09-01
SE378066B (fr) 1975-08-18
FI49773C (fi) 1975-10-10
ZA722243B (en) 1973-11-28
CS209458B2 (en) 1981-12-31
RO64387A (fr) 1979-07-15
HU166989B (fr) 1975-07-28
NL7205865A (fr) 1972-11-01
NO137178C (no) 1978-01-18

Similar Documents

Publication Publication Date Title
BE782651A (fr) Produit a base d'insuline
BE782525A (fr) Distributeur d'aerosols
BE785523A (fr) Cyclopropane-carboxylates d'alpha-cyanobenzyles
BE793246A (fr) Procede d'encapsulation
BE841547Q (fr) Distributeur d'objets a tete
BE784352A (fr) Produit a usage dentaire
IT971806B (it) Composizione termoplastica a base di polibutilenterftalato e proce dimento per la sua preparazione
BE812952A (fr) Machine d'etiquetage
BE777704A (fr) Chelates d'alcane-dioxy-titane
BE821527A (fr) Appareil d'empaquetage d'un materieau calorifuge
BE750581A (fr) Matieres a base d'holosides modifies
BE793306A (fr) Produit cosmetique
BE750582A (fr) Matieres a base d'holosides
BE811489A (fr) Phenoxyalcanecarboxylates d'hydroxyalkyltheophyllines
BE792028A (fr) Catalyseurs a base d'hexahydrotriazine
IT1045864B (it) Accouplement d'ambre
BE781923A (fr) Machine d'extrusion
BE781426A (fr) Matiere d'emballage
BE783753A (fr) Monture d'injection
BE803386A (fr) Emballage-presentoir d'objets
BR7204817D0 (pt) Composicoes a base de fenilarsenoditio
BE768320A (fr) Produit cosmetique a base d'oeufs de poisson
FR2286686A1 (fr) Machine d'oxycoupage
IT948026B (it) Fertilizzanti a base di torba polverizzata
BE783046A (fr) Appareil distributeur d'engrais mineral

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ELI LILLY AND CY

Effective date: 19880430